Remus Pharma Stock Performance

as on April 21, 2026 at 3:56 pm IST

Day's Low
₹650.20
Day's Price Range
₹670.00
₹670.00
2.96%
Downside
52 Week's Low
52 Week's High
₹580.00
52-Week Price Range
₹1,139.50
₹670.00
13.43%
Downside
70.07%
Upside

Remus Pharma share price movements today

Previous Close: ₹650.20
Open: ₹670.00
Volume: 1,200.00
Upper Circuit: ₹780.20
Lower Circuit: ₹520.20
Day's Low - High: ₹650.20 - ₹670.00
52 Week Low - High: ₹580.00 - ₹1,139.50

Remus Pharma Historical Returns

1 Month Return: + 7.15 %
3 Month Return: -0.73 %
1 Year Return: -36.15 %
3 Year Return: + 189.49 %
5 Year Return: + 189.49 %

Remus Pharma Fundamentals

as on April 21, 2026 at 10:26 am IST

Market Cap

₹14,124.38 Cr

Return on Equity (ROE)

12.51

PE Ratio (TTM)

50.3

Return on capital employed (ROCE)

15.94

Beta (LTM)

0.73

P/B Ratio

12.75

Dividend Yield

PEG Ratio

-11.46

Quarterly Earnings Growth YOY

EPS (TTM)

10.4

Sector

Pharmaceuticals

Book Value

217.2

Technical Analysis

Bullish

View Technical Analysis

Remus Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Remus Pharma with its industry peers.

Company	Analyst View	Market Cap(in ₹ Cr)	5 Year CAGR	Debt to Asset Ratio	Net Profit(in ₹ Cr)	Yearly Revenue(in ₹ Cr)
Cohance Lifesciences Ltd	BUY	14,124.38	-5.89%	0.68	264	1,197
Kobo Biotech Ltd	NA	6.84	-10.59%	0.00	-6	NA
Viyash Scientific Ltd	BUY	9,056.70	-4.31%	0.72	32	1,551
Deep Health AI India Ltd	NA	35.75	15.94%	0.51	1	1
Panjon Ltd	NA	42.24	21.33%	0.00	-5	30

See all

Remus Pharma Stock’s Investor Sentiment and Interest

Search interest for Remus Pharmaceuticals Ltd Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 22, 2026 to April 21, 2026

Change:12% versus previous 30 day period

Remus Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

	Mar 2024	Mar 2025
Sales	212.94	620.36
Other Income	2.83	4.98
Total Income	215.77	625.34
Expenses	183.98	574.67
Operating Profit	28.96	45.69
Operating Profit Margin %	13.6%	7.37%
Profit Before Interest, Tax and Depreciation	31.79	50.67
Interest	0.5	1.46
Depreciation	1.12	1.87
Profit Before Tax	30.17	47.34
Tax Paid	5.89	8.92
Profit After Tax	24.28	38.42
Total Net profit including share of profit / Loss from associate company	24.28	38.42
EPS	42.97	65.21
Actual EPS	42.97	65.21
Adjusted EPS	5.37	32.6
Diluted EPS	42.97	65.21

Remus Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

	Mar 2024	Mar 2025
Net Cash from Operating Activities	1.35	6.99
Cash Flow from Investing Activities	-25.31	-10.55
Cash Flow from Financing Activities	27.67	6.07
Net Cash Flow	3.71	2.51

Remus Pharma Stock Shareholding Pattern

Numbers in percentages

	May 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jul 2025	Sep 2025
Promoters	68.37%	69.61%	70.6%	70.66%	70.84%	70.85%	70.85%	70.91%
DII	0.92%	0%	0%	0%	0%	0%	0%	0%
Public	26.03%	27.3%	25.49%	25.61%	25.22%	23.6%	23.32%	23.31%
Total Outstanding Shares	14,73,000	14,73,000	14,73,000	58,92,000	58,92,000	58,92,000	1,17,84,000	1,17,84,000
Total Shareholders	1,743	856	1,124	1,577	1,753	398	2,017	2,032

Insights on Remus Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 70.85% to 70.91% in Sep 2025 quarter
NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 5.03% to 5.02% in Sep 2025 quarter
NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 23.32% to 23.31% in Sep 2025 quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, REMUS stock has moved down by -1.8%

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited, originally incorporated as Remus Pharmaceuticals Private Limited in 2015, is engaged in the marketing and distribution of finished formulations of pharmaceutical drugs. It deals in various drug forms such as capsules, creams, gel, injection, tablets, etc. and supplies therapeutic drugs like ACE inhibitors, anaesthetics, antihistamines, anticancer, etc. Remus Pharmaceuticals' core business includes manufacturing approved finished formulations through loan licence and contract manufacturing, trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers. It has a product portfolio of 429 products, 58 domestic distributors and 139 international distributors. Currently, the company is proposing an initial public offering of up to 388000 Equity Shares through its Fresh Issue.

Listing date: 29 May, 2023

Organisation	Remus Pharmaceuticals Ltd
Industry	Pharmaceuticals
E-voting on shares	Click here to vote

FAQs

What is Remus Pharma share price today?

Remus Pharma share price today stands at ₹670 as on April 21, 2026 at 10:26 am IST. Remus Pharma share today touched a day high of ₹670 and a low of ₹650.2.

What is the 52 week high and 52 week low range for Remus Pharma share?

Remus Pharma touched a 52 week high of ₹1139.5 and a 52 week low of ₹580. Remus Pharma share price today i.e. April 21, 2026 at 10:26 am IST is trending at ₹670, which is -41.20% down from its 52 week high and 15.52% up from its 52 week low.

What is Remus Pharma 's market capitalisation today?

Remus Pharma market capitalisation is ₹766.20 Cr as on April 21, 2026 at 10:26 am IST.

How to buy Remus Pharma shares?

To buy Remus Pharma shares, you need to follow these steps:

Open a Demat account and Trading account on INDmoney
Fund your Trading account
Search for REMUS or Remus Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
Click on Buy or SIP to place an order to invest in Remus Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Remus Pharma trading volume today?

Remus Pharma trading volume is 1,200.00 as on April 21, 2026 at 10:26 am IST. This means that 1,200.00 shares of Remus Pharma were bought and sold on the stock market during today's trading session.